The result showed that both drugs were effective in most cases at modest dosage without causing notable psychological effects 12 months into treatment. Modest and temporary adverse cognitive effects seen earlier in treatment could have been the result of uncontrolled seizure discharge. Improved function was the same in children with epilepsy and controls. Some psychological abnormalities in the children with epilepsy were evident before treatment suggesting early unwanted effects of the epileptic process itself.
The possible psychological effects of antiepileptic drugs have been studied since at least the 1950s but interest in this area of inquiry has increased considerably in the last 15 years or so, with published accounts about antiepileptic medications old and new. Of particular interest to paediatricians are the reports concerning sodium valproate and carbamazepine which, at least in the UK, have largely replaced phenobarbitone and phenytoin as the drugs of choice for treating epilepsy in children. Both these treatments have acquired the reputation of being effective in suppressing seizures, generally without causing harm unless given in very high dosage.
However, this reputation and, indeed, information about the psychological effects of other antiepileptic drugs, is mainly based on findings from studies of uncertain relevance to general, non-specialised paediatric practice (for review see Hirtz and Nelson') . Most investigations have been conducted on adult patients with complicated epilepsies or on normal adult volunteers. Patients studied have sometimes been taking multiple drug treatments or have been mixed regarding intellectual level and age, causing further difficulties in the interpretation of the findings. The psychological assessments employed have usually varied considerably from one study to another and have also frequently been questionable in other ways. Sometimes they have consisted of no more than impressions, and when laboratory (including computerised) measurements have been used, the relationship of such procedures to performance and behaviour in real life situations has not been demonstrated. Very few studies have established pretreatment baselines before assessing treatment over a sufficient period of time to allow possible short and long term effects to be detected. Other requirements not usually observed are the need in longitudinal studies of children to use carefully chosen controls in order to assess developmental influences and, as the effectiveness (or lack of it) of treatment on seizure occurrence may itself have psychological effects, the importance of taking seizure frequency into account over the period of study.
The present study was designed with these various issues in mind in order to make the findings and their implications for clinical practice easier to understand. The focus of the study was not children with epilepsy attending special epilepsy services but those under the care of their local paediatrician, and attending mainstream school. Therefore the children represented those with the more typical and milder forms of seizure disorder, taking treatment characteristically that employed within general non-specialist paediatric practice.
Methods

OVERALL DESIGN
This was a prospective study, over a 12 month period, in which repeated psychological assessments were made on a series of children with newly diagnosed epilepsy before the introduction of a single antiepileptic drug, and then repeated at intervals after the start of treatment. Regarding treatment effects, therefore, the children acted as their own controls over the course of the study. In addition, however, assessments were made of a group of matched non-epileptic children in order to assess practice effects on repeated testing, the effects of special attention given to them during the investigation, and developmental effects over the course of the study. Controls within the epilepsy group by matching for seizure frequency or abundance of seizure discharge were, or course, not possible because of the unpredictability of response to treatment and, in any case, the unfeasibility of trying to assess these seizure variables in this setting other than by ordinary clinical means. All children with epilepsy remained exclusively under the care of their local paediatric service for the duration of the study.
A control group of non-epileptic children was identified as follows. As far as possible each child with epilepsy was matched with a nonepileptic child from the same class at school (to control for teacher differences and/or changes of teacher), of the same sex and age, and of the same overall attainments level as judged by the class teacher. Obvious differences in socioeconomic background were avoided. The original intention was to match every child with epilepsy with a non-epileptic control but this proved impossible in 16 of the 63 cases mainly because parents did not want the school to know that their child had epilepsy, but also because a few schools were so small that a close match for sex, age, and attainment was not possible.
The parents of the patients for possible inclusion in the study and possible control children had been approached by letter with an explanation of the purpose and nature of the study and an invitation for their children to take part. Informed written consent was obtained from the parent or guardian of each child entered into the study. The study was approved by the local research ethics committee.
ASSESSMENTS
(1) Psychological assessments These were carefully selected with the intention of covering a range of cognitive functions and behaviours. A combination was employed of formal testing of general intelligence and attainments, measures of specific cognitive abilities, and questionnaire ratings of behaviour by parents and teachers. All assessments were carried out by a psychologist experienced in working with children and their families. From the information given in the published accounts of these assessments, they all appeared to be psychometrically acceptable. These measures were taken, in the case of children with epilepsy, before antiepileptic drug treatment was started and then repeated at one, three, six, and 12 months after treatment had begun. They were taken at the same point in time as far as possible for each child with epilepsy and control child.
(2) Assessment ofseizure disorder and its treatment Each epileptic child's type of seizure disorder was determined mainly on the basis of the clinical features of the attacks (as recorded by the paediatrician) and results of electroencephalography (EEG). Guidelines were provided to paediatricians emphasising the need for a detailed description of the attacks from the first subjective or objective change to the child's complete recovery, and the circumstances in which the attacks occurred. EEG assessment consisted of at least a standard recording (including overbreathing and photic stimulation phases) and in some cases a sleep deprivation/ natural sleep recording. No structural cerebral lesion was detected in any of the children during the course of the study.
Seizure frequency was judged principally by means of a diary record completed each day by parents or other observers. Date, time, and type of attack was recorded in this way. Differences between control and treatment groups, the two treatment groups, and male and female groups were analysed using Students' t test. This test was also used to detect significant differences between the control group and the two drug groups separately.
In a few cases the first prescribed drug failed to change seizure frequency and the paediatrician then prescribed the other drug. In these cases, only data collected while the child was taking the first drug were analysed.
Results (1) GENERAL CHARACTERISTICS OF THE GROUPS STUDIED
A total of 110 children were included in the study: 63 children with epilepsy and 47 controls. There were no withdrawals during the course of the investigation.
The numbers of children in the epilepsy and control group according to treatment and sex are shown in table 3. There were slightly more boys than girls on treatment and in the trial as a whole, but overall there were no significant differences regarding sex ratios. Table 4 shows the mean ages of the children, by treatment group and sex. Again, there were no statistically significant differences.
For the group of children with epilepsy, the types of seizure and prescribed drugs are shown in There were no significant differences between the different subsequently treated groups and controls.
(b) Changes during treatment Table 8 shows tests on which one or other of the treatment groups were significantly different from the controls at each assessment after the introduction of antiepileptic drug treatment. In all instances the performance of the treatment group was worse than that of controls. In general, the sodium valproate and carbamazepine groups did not differ greatly in the few significant differences seen between each of them and controls. Attentional differences were more consistently seen throughout the repeated assessments, lower focal attention scores characterising the sodium valproate group and lower sustained attention scores the carbamazepine group. In addition, poorer performance than controls was seen in the pegboard measure of visuomotor coordination early in treatment with carbamazepine, and on the more complex digit symbol task during the middle phase of the 12 month period of treatment with sodium valproate.
(6) MEASURES OF BEHAVIOUR (a) Pretreatment No significant differences between boys and girls were seen on any of these measures. Table  9 shows the significant differences that were found between the different seizure type groups and control children. In all differences the epilepsy group score higher than controls.
Collectively, the children with epilepsy showed many significantly worse behaviours compared with controls. A common thread throughout was various aspects of poor attention and 'drowsiness' according to teachers, but in general the absence and partial seizure groups displayed a greater variety of disturbance than the other primary generalised group, sharing a higher level of impulsive/hyperactive and memory problems, as judged by teachers, Table 10 shows the relatively few significant differences in behaviour scores between each treatment group and control children during the course of treatment. No consistent, meaningful pattern is seen up to the six month assessment (with the anomalous result that at three and six months into treatment the children with epilepsy treated with carbamazepine had lower inattention scores than controls), and at 12 months of treatment no differences at all were found.
Discussion
This study was essentially concerned with sodium valproate and carbamazepine as typically used in general paediatric practice. The main findings were that these drugs were equally effective in producing seizure control without common serious adverse physical complications, and that they were also equivalent in being associated with no reduction in intelligence and school attainments over the first 12 months of treatment. Children taking either type of medication showed inferior scores on various tests of specific cognitive ability, mainly those involving aspects of attention, over the 12 month period. In contrast, no behavioural differences between treated children with epilepsy and their controls were found after 12 months of treatment and at earlier stages of treatment only a few inconsistent differences of uncertain significance. It is possible that, in any case, these differences between the children with epilepsy and their controls were not drug effects at all but the result of remaining overt seizures or subtle seizure discharge both of which are capable of producing psychological effects. 7 A main concern in the design of the study was to study schoolchildren with epilepsy in the community under the care of the local paediatric services-that is representative of children with epilepsy in general rather than those attending special clinics or services because of the severity of their disorder. The types ofepilepsy exhibited by the children studied and the high rate of response to antiepileptic treatment both indicate the representative nature of the sample The psychological measures used in this study were carefully selected and the repeat reliabilities of the specific ability tests specially assessed before the study to ensure that the tests were satisfactory in this respect. The repeated assessment procedures, and the test battery, proved acceptable to children, parents and teachers; no child was withdrawn during the study. The psychological assessments before the start of treatment were of particular importance in providing baselines with which later assessments could be compared, but also in identifying pretreatment differences in intelligence and attainment between boys and girls, and the behavioural differences between the normal control children and those with epilepsy before their treatment was started. These differences indicated the need for statistical adjustment to make later comparisons valid.
These pretreatment differences between the children with epilepsy and their controls are of considerable interest in themselves, especially in view of the differences in this respect between the main overall types of epilepsy. The partial seizures subgroup displayed the greatest variety of differences regarding specific abilities, whereas most behavioural differences were seen in the children with absence seizures followed by the partial seizures subgroup. There is no clear separation between these subgroups regarding particular types of differences from controls. Perhaps the most consistent element throughout these differences in the results of specific ability testing and behavioural ratings by both parents and teachers is inattentiveness of one sort or another. The differences in this respect (obviously not attributable to treatment in this instance) are in keeping with the general tendency for children with epilepsy to be considered 'inattentive',8 including being perceived by their teachers as having poor concentration and mental processing and being less alert than their non-epileptic peers even when matched for overall school attainment level.6 In the last mentioned study, children with a past history of epilepsy but no longer taking antiepileptic drugs because of apparent remission of their seizures, were still considered by their teachers to be less alert than their nonepileptic counterparts. The possibility exists that some children with epilepsy, irrespective of type, have a form of attentional disorder, Comparisons between the findings in the present study and other reports concerning children is itself difficult enough in view of differences in study design. The nearest comparison is that with the study by Forsythe et al in which 64 children with newly diagnosed tonic-clonic or partial seizures (age 5 to 14 years) were randomly assigned to treatment with carbamazepine, phenytoin, or sodium valproate." The children were assessed prospectively over a 12 month period on a range of cognitive function tests that were mainly concerned with visual or auditory memory but that also included tests of vigilance, concentration, and speed of information processing. None of these measures were the same as those used in the present study apart from additional measures of intelligence and reading (but only taken after the start of treatment) and no standardised assessments of behaviour were employed. Assessments were performed before treatment and at intervals of one, six, and 12 months after the start of treatment. A fifth of the original sample were lost to the study but in the remainder seizures were controlled in every case. A control group contained 31 children with nocturnal enuresis and nine with migraine. Analysis of the findings was limited for a variety of reasons and the main effect reported was an association between carbamazepine treatment (at modest dosage) and impairment at six and 12 months on a composite measure of memory function. As no pretreatment measures of intelligence and school attainments were made, the relevance of this memory deficit to more global measures, including educational attainment, remains unclear.
The results of other studies of children taking sodium valproate or carbamazepine as single treatments are generally difficult to interpret. Herranz et al reported various adverse behavioural effects in 64% of children after the introduction of sodium valproate, but the assessments used in this study were not psychometrically evaluated and did not include pretreatment measures. 12 In addition the children studied were mixed regarding severity of seizure disorder and intelligence and the body weight related dosage varied widely. Silverstein et al, in another uncontrolled study, reported a wide range of adverse behavioural effects after treatment with carbamazepine but some of the same criticisms apply to this report and its lack of detail makes evaluation difficult. 13 Schain Thirty two fragile X girls were examined of whom 26 were sisters of an affected boy, three were cousins of such a boy, and three had presented because of their own problems and had no affected male relative. All were examined by the same person who was unaware of the cytogenetic findings. Eighteen chromosomally normal sisters of fragile X boys acted as the control group. The two groups of girls were assessed as regards physical features, intelligence, and behaviour.
On clinical examination six features were significantly more common in fragile X girls. They were prominent ears, a long face, shyness, poor eye contact, hand flapping, and hand biting. The control group had a mean IQ of 109 compared to 80 in the fragile X girls of whom 53% had an IQ of less than 85 and 25% less than 70. Fragile X girls with a normal overall IQ often had learning difficulty especially in mathematics. Ten in the fragile X group but none in the control group satisfied criteria for the diagnosis of attention deficit hyperactivity disorder. They were usually impulsive and distractible with a short attention span rather than hyperactive. The authors report that many of the girls improved on treatment with either stimulant drugs or folic acid but they present no controlled data.
This study demonstrates the differences between the fragile X sisters of fragile X boys and their chromosomally normal sisters but it was not a population study and may not, therefore, give a complete picture of the possible range of findings in fragile X girls.
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